Nanostring NCOUNTER Mouse Tumor Signaling 360 Pa - 12 Assays NSTG115000419

NanoString nCounter Mouse Tumor Signaling 360
780-plex: 760 mouse target genes + 20 reference genes

As therapeutics that target tumor signaling evolve, a greater understanding of tumor signaling is required as well as a better understanding of the interactions of tumor cells with the tissue milieu. The Tumor Signaling 360 Panel is intended to play this exact role, enabling deeper profiling of the tumor that is complete, yet focused on signaling pathways of interest for targeted therapeutic development. Covering hundreds of genes involved in tumorigenesis, metastasis, and inflammation, the nCounter Tumor Signaling 360 Panel offers a holistic view of the biology of the tumor, microenvironment, and immune response with an emphasis on dysfunctional cell signaling in cancer.

More information at: https://nanostring.com/products/ncounter-assays-panels/oncology/tumor-signaling-360/